TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model

User: Guest

Title:: TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model
Document type:: Zeitschriftenaufsatz
Author(s):: Schober, Sebastian J. ; Thiede, Melanie ; Gassmann, Hendrik ; von Ofen, Anna Josefine ; Knoch, Pia ; Eck, Jennifer ; Prexler, Carolin ; Kordass-Wally, Corazon ; Hauer, Julia ; Burdach, Stefan ; Holm, Per Sonne ; Thiel, Uwe
Keywords:: Immunology ; pediatric sarcoma ; Ewing sarcoma ; oncolytic virotherapy ; TCR-transgenic T cells ; combination immunotherapy
Journal title:: Frontiers in Immunology
Year:: 2024
Journal volume:: 15
Fulltext / DOI:: doi:10.3389/fimmu.2024.1330868
Publisher:: Frontiers Media S.A.
E-ISSN:: 1664-3224
Date of publication:: 22.01.2024
CC license:: by, https://creativecommons.org/licenses/by/4.0

BibTeX

Occurrences: